Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1991British Journal of Clinical PharmacologyOpen Access

Preventive effects of octreotide (SMS 201‐995) on diabetic ketogenesis during insulin withdrawal.

View Full Paper
Ask AI
Bookmark
Share

Authors

PDPeter DiemKantonsarchäologieRRR. P. RobertsonUniversity of Bern

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Diem et al. (1991) studied this question.

synapsesocial.com/papers/6aa301b59641e5d546c07afehttps://doi.org/10.1111/j.1365-2125.1991.tb03952.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–9951985 · 399 citations
  2. 2The Regulation of Plasma Ketone Body Concentration by Counter-regulatory Hormones in Man: II. Effects of Growth Hormone in Diabetic Man1978 · 65 citations
  3. 3Reduced Postprandial Hyperglycemia After Subcutaneous Injection of a Somatostatin-Analogue (SMS 201-995) in Insulin-dependent Diabetes Mellitus1985 · 49 citations
  4. 4Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas1974 · 523 citations
  5. 5Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–9951986 · 120 citations